Maine CDC Breast and Cervical Health Program (MBCHP)

---

Breast and Cervical Cancer Screening Guidelines/Recommendations

---

Breast Cancer Screening:

Clinical Summary of U.S. Preventive Services Task Force Recommendation

• Screening for Breast Cancer: U.S. Preventive Services Task Force, 2002
• Screening for Breast Cancer: U.S. Preventive Services Task Force, November 2009
• Screening for Breast Cancer: U.S. Preventive Services Task Force, January 2016

American College of Physicians

• Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians (April 2019)

---

Cervical Cancer Screening:

Clinical Summary of U.S. Preventive Services Task Force Recommendation

• Screening for Cervical Cancer: U.S. Preventive Services Task Force, 2012
• Screening for Cervical Cancer: U.S. Preventive Services Task Force, 2018

The American Congress of Obstetricians and Gynecologists (ACOG) Recommendations

• Ob-Gyns Recommend Women Wait 3 to 5 Years Between Pap Tests

---

 

American Society for Colposcopy and Cervical Pathology (ASCCP)

The Maine CDC Breast and Cervical Health Program (MBCHP) obtained permission from the American Society for Colposcopy and Cervical Pathology (ASCCP) to provide the following links:

• 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
• 2013 Consensus Guidelines Algorithms Updated Consensus Guidelines for Managing Abnormal Cervical Cancer
  Screening Tests and Cancer Precursors
  

The copyright of the algorithms, both on the ASCCP web site and in the original Journal of Lower Genital Tract Disease article, is owned by the ASCCP.

 

NOTE:

The Maine CDC Breast and Cervical Health Program (MBCHP) can only reimburse participating providers for services related to breast or cervical cancer screening and diagnostics– MBCHP Billing Information

Updated April 16, 2019